Cargando…

P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS

Detalles Bibliográficos
Autores principales: Song, Ga-Young, Jung, Sung-Hoon, Ahn, Seo-Yeon, Kim, Mihee, Ahn, Jae-Sook, Lee, Je-Jung, Kim, Hyeoung-Joon, Bae Moon, Jang, Woong Yoo, Su, Young Kwon, Seong, Min, Jung-Joon, Bom, Hee-Seung, Kang, Sae-Ryung, Hwan Yang, Deok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430899/
http://dx.doi.org/10.1097/01.HS9.0000971672.64743.b7
_version_ 1785091069961043968
author Song, Ga-Young
Jung, Sung-Hoon
Ahn, Seo-Yeon
Kim, Mihee
Ahn, Jae-Sook
Lee, Je-Jung
Kim, Hyeoung-Joon
Bae Moon, Jang
Woong Yoo, Su
Young Kwon, Seong
Min, Jung-Joon
Bom, Hee-Seung
Kang, Sae-Ryung
Hwan Yang, Deok
author_facet Song, Ga-Young
Jung, Sung-Hoon
Ahn, Seo-Yeon
Kim, Mihee
Ahn, Jae-Sook
Lee, Je-Jung
Kim, Hyeoung-Joon
Bae Moon, Jang
Woong Yoo, Su
Young Kwon, Seong
Min, Jung-Joon
Bom, Hee-Seung
Kang, Sae-Ryung
Hwan Yang, Deok
author_sort Song, Ga-Young
collection PubMed
description
format Online
Article
Text
id pubmed-10430899
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104308992023-08-17 P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS Song, Ga-Young Jung, Sung-Hoon Ahn, Seo-Yeon Kim, Mihee Ahn, Jae-Sook Lee, Je-Jung Kim, Hyeoung-Joon Bae Moon, Jang Woong Yoo, Su Young Kwon, Seong Min, Jung-Joon Bom, Hee-Seung Kang, Sae-Ryung Hwan Yang, Deok Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430899/ http://dx.doi.org/10.1097/01.HS9.0000971672.64743.b7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Song, Ga-Young
Jung, Sung-Hoon
Ahn, Seo-Yeon
Kim, Mihee
Ahn, Jae-Sook
Lee, Je-Jung
Kim, Hyeoung-Joon
Bae Moon, Jang
Woong Yoo, Su
Young Kwon, Seong
Min, Jung-Joon
Bom, Hee-Seung
Kang, Sae-Ryung
Hwan Yang, Deok
P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS
title P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS
title_full P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS
title_fullStr P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS
title_full_unstemmed P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS
title_short P1194: PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F-FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE-CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS
title_sort p1194: prognostic significance of sequential 18f-fdg pet/ct during the treatment of anthracycline-containing frontline chemotherapy in peripheral t cell lymphomas
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430899/
http://dx.doi.org/10.1097/01.HS9.0000971672.64743.b7
work_keys_str_mv AT songgayoung p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT jungsunghoon p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT ahnseoyeon p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT kimmihee p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT ahnjaesook p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT leejejung p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT kimhyeoungjoon p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT baemoonjang p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT woongyoosu p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT youngkwonseong p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT minjungjoon p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT bomheeseung p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT kangsaeryung p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas
AT hwanyangdeok p1194prognosticsignificanceofsequential18ffdgpetctduringthetreatmentofanthracyclinecontainingfrontlinechemotherapyinperipheraltcelllymphomas